Challenges and opportunities during the COVID-19 pandemic: Treating patients for substance use disorders during the perinatal period

https://doi.org/10.1016/j.ypmed.2021.106742Get rights and content

Highlights

  • COVID-19 driven treatment changes altered birthing patients access and engagement.

  • COVID-19 pandemic changed substance use disorder treatment care for birthing people.

  • Pregnant and postpartum patients with substance use problems deserve equitable care.

Abstract

The coronavirus disease 2019 (COVID-19) pandemic exacerbated the opioid use disorder epidemic and accelerated alcohol and other substance use disorders. Sudden health care service delivery changes during the COVID-19 pandemic created both challenges and opportunities for all patients with substance use disorders including the use of virtual or telemedicine visits, medication access issues and ensuring access to naloxone when supplies cannot be handed out. Unique challenges for pregnant and post-partum patients with substance use disorders includes some evidence of reduced access to medication to treat opioid use disorders and changes in delivery protocols that isolate birthing people from supports. Opportunities for all patients with substance use disorders include virtual platforms presenting positive opportunities for treatment. They are time efficient, eliminate transportation barriers, and potentially reduce childcare barriers. For pregnant and post-partum patients with substance use disorders, hybrid models of telemedicine and in-person visits reduced no-show visit rates and increased flexibility in medication dosing regimens. Thus, there is a unique opportunity to study the success of different virtual care models given the variety of implemented strategies. The COVID-19 pandemic provides an unprecedented opportunity to dramatically transform standard care approaches to help optimize care for all patients, including pregnant and post-partum people.

Keywords

Pregnancy
Pandemic
COVID-19
Postpartum
Opioid use disorder
Alcohol
Substance use disorder

Cited by (0)

View Abstract